Biotechnology Novo and Pfizer in Metsera takeover battle In a surprising move, Novo Nordisk A/S has overbid Pfizer Inc.’s M&A tender for Metsera Inc by US$1.9bn. Metsera develops GLP-1 and amylin-based therapeutics. GLP-1 (glucagon-like peptide-1) increases insulin secretion. It suppresses glucagon production. This lowers blood sugar levels. Amylin slows gastric emptying. It increases the feeling of satiety. Long-acting formulation The lead candidate, MET-097i, […] Written by Thomas Gabrielczyk November 1, 2025November 1, 2025 Saving Bookmark this article Bookmarked
Biotechnology GSK adds to COPD drug push with Empirico deal GSK is shelling out $85 million up front, and possibly $745 million overall, for an RNA-based therapy it sees helping a "broad spectrum" of people with the chronic lung condition. Written by Kristin Jensen October 29, 2025October 29, 2025 Saving Bookmark this article Bookmarked
Biotechnology Nurses’ Crucial Role in Suicide Prevention: A Review In an age where mental health awareness is gaining momentum, one crucial aspect has emerged as pivotal in combatting a growing crisis: suicide prevention. A recent comprehensive scoping review conducted by Riedel, Feinauer, Jacob, and their colleagues has examined the multifaceted roles and responsibilities of nurses in suicide prevention efforts. The article, published in BMC […] Written by Bioengineer October 26, 2025October 26, 2025 Saving Bookmark this article Bookmarked
Biotechnology Novartis spends billions in 2025 Newsletter Signup – Under Article / In Page “*” indicates required fields The year 2024 was regarded as a reset year with lackluster deal performance in the biopharma industry. This year was predicted to witness a surge in mergers and acquisitions (M&As) deals in the sector and in the latter half of the year, the pharma giant Novartis has struck big. Novartis expanding cardiovascular research Novartis buys Tourmaline […] Written by Roohi Mariam Peter October 22, 2025October 22, 2025 Saving Bookmark this article Bookmarked
Biotechnology ESMO: AstraZeneca believes latest data 'validate' going it alone on next-gen ADCs Europe’s leading cancer conference may be swimming in ADC data, but AstraZeneca remains convinced its in-house pipeline sets the pharma apart. Written by Admin October 19, 2025October 19, 2025 Saving Bookmark this article Bookmarked
Biotechnology Tubulis secures €308m in record-breaking Series C financing Munich-based biotech Tubulis has closed a €308m (US$361m) Series C financing round – the largest of its kind for a European biotechnology company at the Series C stage and also the world’s largest financing for a private ADC (antibody–drug conjugate) developer. The round was led by Venrock Healthcare Capital Partners, joined by new investors Wellington […] Written by Georg Kääb October 16, 2025October 16, 2025 Saving Bookmark this article Bookmarked
Biotechnology Regeneron, with ‘game-changing’ new data, to seek approval of hearing loss gene therapy Study results published in The New England Journal of Medicine show the therapy significantly improved hearing in nearly a dozen children with a rare, genetic form of deafness. Written by Jacob Bell October 12, 2025October 12, 2025 Saving Bookmark this article Bookmarked
Biotechnology Unraveling Ageing-Parkinson’s Link: PD-AGE Advances In the rapidly evolving field of neurodegenerative disease research, Parkinson’s disease (PD) remains a focal point due to its complex interplay with the ageing process. A pioneering initiative led by the PD-AGE network seeks to illuminate this nexus through a groundbreaking study that emphasizes the urgent need for standardisation in in vitro models and experimental […] Written by Bioengineer October 9, 2025October 9, 2025 Saving Bookmark this article Bookmarked
Biotechnology The biggest biotech funding rounds in September 2025 Newsletter Signup – Under Article / In Page “*” indicates required fields The companies uniQure, Dianthus Therapeutics, and Mineralys Therapeutics bagged the biggest biotech funding rounds overall in September 2025 across private and public funding types. In this article, we break down last month’s private and public fundraising activity, looking at the largest rounds in […] Written by Willow Shah-Neville October 6, 2025October 6, 2025 Saving Bookmark this article Bookmarked
Biotechnology Singapore drug discovery platform heads to Nasdaq via SPAC deal An AI-driven drug discovery platform will receive a step up onto the Nasdaq via a reverse merger with a blank check company. Written by Admin October 2, 2025October 2, 2025 Saving Bookmark this article Bookmarked
New Arabidopsis BIK1 Alleles Confirm Immunity Role In a groundbreaking study poised to redefine our understanding of plant immunity, researchers have unveiled novel insights into the pivotal roles of the receptor-like cytoplasmic kinases BIK1 and PBL1 in Arabidopsis. These kinases, previously studied primarily through single transfer DNA (T-DNA) insertional mutant alleles, are reaffirmed as central players in the plant’s pattern-triggered immunity (PTI) […] Written by Bioengineer January 7, 2026January 7, 2026 Saving Bookmark this article Bookmarked
Climate Action Costs More in the Global South. Here’s Why. – State of the Planet Clean energy technologies have become more affordable around the world. Yet for many countries in the Global South, the cost of transitioning to a low-carbon economy remains disproportionately high. But not because the equipment is more expensive: in fact, solar and wind components are often imported at comparable prices around the world, as global manufacturing scale and […] Written by Guest January 7, 2026January 7, 2026 Saving Bookmark this article Bookmarked
New Arabidopsis BIK1 Alleles Confirm Immunity Role In a groundbreaking study poised to redefine our understanding of plant immunity, researchers have unveiled novel insights into the pivotal roles of the receptor-like cytoplasmic kinases BIK1 and PBL1 in Arabidopsis. These kinases, previously studied primarily through single transfer DNA (T-DNA) insertional mutant alleles, are reaffirmed as central players in the plant’s pattern-triggered immunity (PTI) […] Written by Bioengineer January 7, 2026January 7, 2026 Saving Bookmark this article Bookmarked
Climate Action Costs More in the Global South. Here’s Why. – State of the Planet Clean energy technologies have become more affordable around the world. Yet for many countries in the Global South, the cost of transitioning to a low-carbon economy remains disproportionately high. But not because the equipment is more expensive: in fact, solar and wind components are often imported at comparable prices around the world, as global manufacturing scale and […] Written by Guest January 7, 2026January 7, 2026 Saving Bookmark this article Bookmarked
Corcept Receives Complete Response Letter for Relacorilant as a Treatment for Patients with Hypercortisolism REDWOOD CITY, Calif.–(BUSINESS WIRE)–Dec. 31, 2025– Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and… Written by Admin January 7, 2026January 7, 2026 Saving Bookmark this article Bookmarked
Understanding PMDA Validation Rules v5.0 The Pharmaceuticals and Medical Devices Agency (PMDA) in Japan has always led the charge in ensuring the safety and efficacy of drug development. Their latest update, the PMDA Validation Rules version 5.0, which took effect on April 1, 2024, marks another significant step in this mission. Let’s break down what these new rules mean and […] Written by Admin July 10, 2024July 10, 2024 Saving Bookmark this article Bookmarked
Enhance Your SEND Submissions! Join PointCross on May 29th, 2024, at 12 PM EST / 9 AM PST for a must-attend webinar: The Most Common Issues in Preparing SEND. Ideal for professionals in data submission and regulatory compliance, this webinar offers valuable insights from our seasoned experts. Why Attend? Why PointCross? With over 10 years of experience and more […] Written by Admin May 23, 2024May 23, 2024 Saving Bookmark this article Bookmarked